Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated

Journal of Investigative Dermatology

Volumn 131, Issue 6, 2011, Pages 1322-1330

  Pettersen, Julia S ^a   Fuentes Duculan, Judilyn ^b   Suárez Farĩas, Mayte ^b   Pierson, Katherine C ^b   Pitts Kiefer, Alexander ^a   Fan, Linda ^a   Belkin, Daniel A ^a   Wang, Claire Q F ^b   Bhuvanendran, Shivaprasad ^b   Johnson Huang, Leanne M ^b   Bluth, Mark J ^a   Krueger, James G ^b   Lowes, Michelle A ^b   Carucci, John A ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 CHEMOKINE; CD163 ANTIGEN; CD209 ANTIGEN; CD68 ANTIGEN; CHEMOKINE; CYTOKINE; GELATINASE B; INTERLEUKIN 12; INTERLEUKIN 23P19; INTERLEUKIN 23P40; INTERLEUKIN 7 RECEPTOR; STAT1 PROTEIN; STROMELYSIN 3; UNCLASSIFIED DRUG;

ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKOCYTE ACTIVATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 85027931781     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.9     Document Type: Article

References (66)

1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-45 (Pubitemid 32173595)
2. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254-65 (Pubitemid 34189413)
3. Biswas SK, Gangi L, Paul S et al. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 107:2112-22 (Pubitemid 43289397)
4. Bluth MJ, Zaba LC, Moussai D et al. (2009) Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. J Invest Dermatol 129:2451-62
5. Bonecchi R, Sozzani S, Stine JT et al. (1998) Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 92:2668-71 (Pubitemid 28469077)
6. Brantsch KD, Meisner C, Schonfisch B et al. (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9:713-20
7. Buergy D, Weber T, Maurer GD et al. (2009) Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Int J Cancer 125:894-901
8. Carucci JA (2004) Cutaneous oncology in organ transplant recipients: meeting the challenge of squamous cell carcinoma. J Invest Dermatol 123: 809-16 (Pubitemid 39391923)
9. Chamian F, Lowes MA, Lin SL et al. (2005) Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA 102:2075-80 (Pubitemid 40262014)
10. + T cells. Eur J Immunol 40:1396-407
11. De Oliveira MV, Fraga CA, Gomez RS et al. (2009) Immunohistochemical expression of interleukin-4, -6, -8, and -12 in inflammatory cells in surrounding invasive front of oral squamous cell carcinoma. Head Neck 31:1439-46
12. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-74 (Pubitemid 37328786)
13. El-Rouby DH (2010) Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas. J Oral Pathol Med 39:559-64
14. Fadok VA, Bratton DL, Konowal A et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890-8 (Pubitemid 28096086)
15. Forbes E, Van Panhuys N, Min B et al. (2010) Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses. Immunol Cell Biol 88:240-3
16. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC et al. (2010) A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 130:2412-22
17. Gocheva V, Wang HW, Gadea BB et al. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24:241-55
18. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604
19. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-64 (Pubitemid 41746764)
20. Gustafsson C, Mjosberg J, Matussek A et al. (2008) Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 3:e2078
21. Haider AS, Peters SB, Kaporis H et al. (2006) Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126:869-81
22. Huang SJ, Hijnen D, Murphy GF et al. (2009) Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol 129:2676-85
23. +) T cells in the antitumor immune response. J Exp Med 188:2357-68 (Pubitemid 29028508)
24. + T cells in a Th2 dominant microenvironment. J Invest Dermatol 127:2391-8 (Pubitemid 47619759)
25. Katakura T, Miyazaki M, Kobayashi M et al. (2004) CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 172: 1407-13 (Pubitemid 38116782)
26. Kodelja V, Muller C, Politz O et al. (1998) Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 160:1411-8 (Pubitemid 28093442)
27. Koller FL, Hwang DG, Dozier EA et al. (2010) Epithelial interleukin-4 receptor expression promotes colon tumor growth. Carcinogenesis 31:1010-7
28. Kryczek I, Banerjee M, Cheng P et al. (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141-9
29. Kwan WH, Navarro-Sanchez E, Dumortier H et al. (2008) Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis 2:e311
30. Lamb J, Crawford ED, Peck D et al. (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929-35 (Pubitemid 44497995)
31. Landolfo S, Gribaudo G, Angeretti A et al. (1995) Mechanisms of viral inhibition by interferons. Pharmacol Ther 65:415-42
32. Lathers DM, Young MR (2004) Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 25:220-8 (Pubitemid 38229413)
33. Leek RD, Lewis CE, Whitehouse R et al. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-9 (Pubitemid 26338061)
34. Li-Weber M, Krammer PH (2003) Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 3:534-43 (Pubitemid 37328673)
35. Lin EY, Li JF, Gnatovskiy L et al. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66:11238-46 (Pubitemid 46009952)
36. Lin EY, Pollard JW (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67:5064-6 (Pubitemid 46997238)
37. Mantovani A, Sica A, Sozzani S et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-86 (Pubitemid 39457982)
38. Martinez FO, Gordon S, Locati M et al. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303-11 (Pubitemid 44715100)
39. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451-83
40. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-69
41. Moussai D, Mitsui H, Pettersen JS et al. (2011) The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J Invest Dermatol 131:229-36
42. Nonomura N, Takayama H, Kawashima A et al. (2010) Decreased infiltration of macrophage scavenger receptor-positive cells in initial negative biopsy specimens is correlated with positive repeat biopsies of the prostate. Cancer Sci 101:1570-3
43. Pinto CA, Carvalho PE, Antonangelo L et al. (2003) Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clin Cancer Res 9:3098-104 (Pubitemid 36993272)
44. Pries R, Wollenberg B (2006) Cytokines in head and neck cancer. Cytokine Growth Factor Rev 17:141-6 (Pubitemid 43949076)
45. Puig-Kroger A, Serrano-Gomez D, Caparros E et al. (2004) Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. J Biol Chem 279:25680-8 (Pubitemid 38756831)
46. Romieu-Mourez R, Solis M, Nardin A et al. (2006) Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res 66:10576-85 (Pubitemid 44799781)
47. Saha B, Jyothi Prasanna S, Chandrasekar B et al. (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50:1-14
48. Schroder K, Hertzog PJ, Ravasi T et al. (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-89 (Pubitemid 38174573)
49. Schutyser E, Richmond A, Van Damme J (2005) Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol 78:14-26 (Pubitemid 40979939)
50. Shabo I, Stal O, Olsson H et al. (2008) Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123:780-6 (Pubitemid 352032402)
51. Shah SA, Spinale FG, Ikonomidis JS et al. (2010) Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung. J Thorac Cardiovasc Surg 139:984-90
52. Sica A, Schioppa T, Mantovani A et al. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-27
53. Siveen KS, Kuttan G (2009) Role of macrophages in tumour progression. Immunol Lett 123:97-102
54. Soilleux EJ, Morris LS, Leslie G et al. (2002) Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopula-tions in situ and in vitro. J Leukoc Biol 71:445-57
55. Steidl C, Lee T, Shah SP et al. (2010) Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362:875-85
56. Stout RD, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76:509-13 (Pubitemid 39129080)
57. Suarez-Farinas M, Lowes MA, Zaba LC et al. (2010) Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS One 5:e10247
58. Subramanian A, Kuehn H, Gould J et al. (2007) GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 23:3251-3 (Pubitemid 350187532)
59. Subramanian A, Tamayo P, Mootha VK et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-50 (Pubitemid 41528093)
60. Takeda K, Tanaka T, Shi W et al. (1996) Essential role of Stat6 in IL-4 signalling. Nature 380:627-30 (Pubitemid 26119015)
61. Todaro M, Lombardo Y, Francipane MG et al. (2008) Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 15:762-72 (Pubitemid 351405081)
62. Van Kempen LC, Ruiter DJ, Van Muijen GN et al. (2003) The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 82:539-48 (Pubitemid 38008835)
63. Wang YC, He F, Feng F et al. (2010) Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res 70:4840-9
64. Weinberg AS, Ogle CA, Shim EK (2007) Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 33:885-99 (Pubitemid 47106729)
65. + macrophages. J Clin Invest 117:2517-25 (Pubitemid 47494353)
66. Zhao ZS, Chu YQ, Ye ZY et al. (2010) Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopatho-logic significance. Hum Pathol 41:686-96